CClinicalTrials.gg
Not yet recruitingNCT07725341Updated Jul 27, 2026

Single Session Intervention for Postpartum Intrusive Thoughts

An interventional study of Postpartum Intrusive Thoughts and Anxiety (PITA) Program in Postpartum Intrusive Thoughts, sponsored by Mclean Hospital. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-27.

Sponsored by Mclean Hospital · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Despite their impact, postpartum intrusive thoughts- unwanted, distressing thoughts, images, and urges often about harming one's infant, are common yet overlooked. This can lead to distress, shame, impairment, and for some, diagnoses of depression, anxiety, or OCD. This project aims to adapt and test a brief, accessible intervention targeting misinterpretation of postpartum intrusive thoughts.

Read the detailed description

This proposal aims to adapt and refine two evidence-based interventions into a scalable, personalized, digital intervention targeting the misinterpretation of intrusive thoughts during the postpartum period. The intervention will be piloted for its effectiveness, and its implementation outcomes will be examined by recruiting new parents (N = 30) in an open trial, aiming for a target of N = 24, accounting for attrition. This study will recruit across the U.S. from the leading digital resource for new and expectant parents with a nationally representative user population, and will facilitate its reach to people with distressing intrusive thoughts regardless of where they live - rural, suburban, or urban areas. Outcomes to be evaluated include: target engagement (interpretation bias), changes in our primary outcome (intrusive thoughts severity), and feasibility and acceptability (see Measures).

In this pilot trial, our central hypothesis is the intervention will be feasible, acceptable, and meet a priori benchmarks for preliminary effectiveness in reducing interpretation bias and improving outcomes for clinical levels of postpartum intrusive thoughts, parent anxiety, and psychosocial functioning. Testing effectiveness and implementation will inform strategies to refine and integrate low-burden digital interventions for new parents into real-world service delivery, supporting a fully-powered hybrid type 1 trial and enabling dissemination of a brief, accessible, low-cost intervention to reduce the perinatal intrusive thoughts and improve public health for new parents.

02

Conditions studied

  • Postpartum Intrusive Thoughts

Keywords

  • intrusive thoughts
  • postpartum
03

In context

Lead sponsor

Mclean Hospital is the lead sponsor of 181 studies on the registry; 32 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 10 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. age 18 or older
  2. fluent in English, per self-report
  3. became a parent of an infant in the past 3 months (biological, adoptive, or caregiving parent)
  4. elevated interpretation bias (score of >131 on Obsessive Beliefs Questionnaire-44 (OBQ-44; 1 SD above mean of non-clinical sample)
  5. endorse, "In the past week, have you had images pop into your head that you didn't want, like violent or horrible scenes or something of a sexual nature?" or "how about having urges to do something that kept coming back to you even though you didn't want them to, like an urge to harm a loved one?"

Exclusion criteria

Exclusion criteria:

None

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Postpartum Intrusive Thoughts and Anxiety (PITA) program

    One-time psychoeducation intervention

    Behavioral: Postpartum Intrusive Thoughts and Anxiety (PITA) Program

Interventions

  • BehavioralPostpartum Intrusive Thoughts and Anxiety (PITA) Program

    A single session intervention (15-30 minutes) of psychoeducational material about postpartum intrusive thoughts

06

What researchers measure

Primary outcomes

  1. Dimensional Obsessive Compulsive Scale - Unacceptable Thoughts subscale

    4-item subscale measuring severity of intrusive thoughts

    Time frame: Pre-intervention and 2-week follow-up

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Our clinical trial will be registered on clinicaltrials.gov and data for all research subjects will be submitted to the NIMH National Data Archive (NDA) using the data dictionaries available in NDA.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07725341
Lead sponsor
Mclean Hospital
Responsible party
Martha J Falkenstein (Assistant Professor, Mclean Hospital) — Principal investigator
First posted
Jul 24, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Aug 1, 2029 (estimated)
Completion
Sep 30, 2029 (estimated)
Last update
Jul 27, 2026

Study contacts

Martha J Falkenstein, PhD
Contact
mfalkenstein@mclean.harvard.edu
617-855-4424

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion